International conference on protein stability – The gap between industry and administration
course number: 7039
- Hot Topics
- Research and Development
Workshop program / Flyer
- 7039_RealHope.pdf (512 KB)
Date and venue
Start:
2025-05-13, 13:00
End:
2025-05-14, 16:30
Add appointment to calendar
Venue
Södertälje Science Park
Kvarnbergagatan 12
151 36 Södertälje
Sweden
E-mail: info@sscp.se
https://sscp.se/in-english/
Summary
About RealHOPE
The RealHOPE (Real-world handling of protein drugs - Exploration, evaluation and education) project is a joint
collaboration by a consortium of 26 partners consisting of pharmaceutical and medical device companies, instrument- and app developers and logistics companies together with universities, institutes, hospital pharmacies, pharmacists and a patient organization from 6 European countries and US. Funded by EU and EFPIA partners and coordinated by RISE Research Institutes of Sweden, with Sanofi as a tech lead, the year project will be active until June 2025.
The RealHOPE consortium covers in-use aspects of protein drug stability, investigating and recognising the critical steps where stability can be compromised. With the common goal to support a safe and efficient use of these medications for patients, whose life often depend on them, RealHOPE have developed concrete and practical recommendations and tools for simulation of real-life events, explored mitigation of critical handling steps, and developed educational material to ensure careful handling by healthcare and pharmacy staff as well as patients. From this, recommendations and guidelines will result that have an immediate impact on drug development, distribution, and handling.
The RealHOPE project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement N° 101007939 (RealHOPE). This Joint Undertaking receives support from the
European Union’s Horizon 2020 research and innovation programme and EFPIA.
More abour RealHOPE you can find here: www.realhope.se
Call for papers
The abstract should be prepared using Microsoft Word as half page (A4) typed in Times New Roman, font size 12. Deadline for abstract submission: 31 March 2025. Please submit your abstracts by e-mail to Valentina Marinkova at marinkova@apv-mainz.de.
Exhibition
As an exhibitor you will be invited to attend the sessions and the networking dinner in the evening. Price for a tabletop space with table, chairs and power supply is 990 EUR plus one mandatory full conference registration. Don‘t see an option that corresponds to your requirements? Kindly contact: Valentina Marinkova, E-mail: marinkova@apv-mainz.de
Objective
The objective of this symposium/conference is to create an arena for discussions on the recent research and industrial interest in the reality and impact of inuse handling of protein medicines. Real-life handling, important stress factors, simulation, mitigations as formulation and education will be covered. The vision is to bring together the different stakeholder groups involved and affected; patients, pharmacists, academic and industrial researchers.
Organizer(s)
Kurfürstenstraße 59
55118 Mainz
Germany
Dr. Martin Bornhöft
Phone: +49 6131 9769-0
E-mail: info@apv-mainz.de
https://www.apv-mainz.de
Cooperation partner(s)
RealHOPE
The RealHOPE (Real-world handling of protein drugs - Exploration, evaluation and education) project is a joint collaboration by a consortium of 26 partners consisting of pharmaceutical and medical device companies, instrument- and app developers and logistics companies together with universities, institutes, hospital pharmacies, pharmacists and a patient organization from 6 European countries and US. Funded by EU and EFPIA partners and coordinated by RISE Research Institutes of Sweden, with Sanofi as a tech lead, the year project will be active until June 2025.
Prices
All prices free of VAT